SCHEMBL13818064

SCHEMBL13818064

CC(=O)c1c(O)c2cnccc2[nH]c1=O

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 8/20 0.57
▸ PARP1 P09874 2/20 0.54
▸ KDM5B Q9UGL1 2/20 0.53
▸ KDM4E B2RXH2 2/20 0.47
▸ GRIN2D O15399 1/20 0.45
▸ GRIN3B O60391 1/20 0.45
▸ GRIN1 Q05586 1/20 0.45
▸ GRIN2A Q12879 1/20 0.45
▸ GRIN2B Q13224 1/20 0.45
▸ GRIN2C Q14957 1/20 0.45
▸ GRIN3A Q8TCU5 1/20 0.45
▸ DAO P14920 2/20 0.45
▸ FEN1 P39748 1/20 0.44
▸ ACHE P22303 2/20 0.44
▸ KDM5C P41229 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13818061 0.88 KDM5A (0.72) KDM5APARP1KDM5BKDM4EGRIN2D
SCHEMBL13708891 0.86 PARP1 (0.55) KDM5APARP1KDM5BKDM4EGRIN2D
SCHEMBL25432233 0.85 PARP1 (0.54) KDM5APARP1KDM5BKDM4EDAO
SCHEMBL31139875 0.85 PARP1 (0.54) KDM5APARP1KDM5BKDM4EDAO
SCHEMBL1061771 0.81 KDM5A (0.81) KDM5APARP1KDM5BKDM4EALDH1A1
SCHEMBL2284247 0.78 KDM4E (0.69) KDM4EDAOALDH1A1GAAMAPT
SCHEMBL7123033 0.76 PARP1 (0.50) KDM5APARP1KDM5BGRIN2DGRIN3B
SCHEMBL31139842 0.76 KDM5A (0.57) KDM5APARP1KDM5BKDM4EDAO
SCHEMBL25430812 0.76 KDM5A (0.57) KDM5APARP1KDM5BKDM4EDAO
SCHEMBL10134606 0.73 PARP1 (0.79) KDM5APARP1KDM5BKDM4EDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 — — US disclosed
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143368-A1 Use of Cinnamoyl Compound COL2A1, COL1A1, SMAD2 KDM5A 1427/4885PARP1 3025/4885KDM5B 1172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback